JP2005510505A5 - - Google Patents

Info

Publication number
JP2005510505A5
JP2005510505A5 JP2003539722A JP2003539722A JP2005510505A5 JP 2005510505 A5 JP2005510505 A5 JP 2005510505A5 JP 2003539722 A JP2003539722 A JP 2003539722A JP 2003539722 A JP2003539722 A JP 2003539722A JP 2005510505 A5 JP2005510505 A5 JP 2005510505A5
Authority
JP
Japan
Prior art keywords
composition
peroxide
amount
vaginal
source
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003539722A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005510505A (ja
JP5153049B2 (ja
Filing date
Publication date
Priority claimed from US10/278,910 external-priority patent/US7709026B2/en
Application filed filed Critical
Publication of JP2005510505A publication Critical patent/JP2005510505A/ja
Publication of JP2005510505A5 publication Critical patent/JP2005510505A5/ja
Application granted granted Critical
Publication of JP5153049B2 publication Critical patent/JP5153049B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003539722A 2001-10-29 2002-10-28 膣感染を処置又は予防するための低濃度のペルオキサイド Expired - Fee Related JP5153049B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US33068301P 2001-10-29 2001-10-29
US60/330,683 2001-10-29
US10/278,910 2002-10-24
US10/278,910 US7709026B2 (en) 2001-10-29 2002-10-24 Low concentration of peroxide for treating or preventing vaginal infections
PCT/EP2002/012043 WO2003037382A1 (en) 2001-10-29 2002-10-28 Low concentration of peroxide for treating or preventing vaginal infections

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010152148A Division JP2010248232A (ja) 2001-10-29 2010-07-02 膣感染を処置又は予防するための低濃度のペルオキサイド

Publications (3)

Publication Number Publication Date
JP2005510505A JP2005510505A (ja) 2005-04-21
JP2005510505A5 true JP2005510505A5 (cg-RX-API-DMAC7.html) 2005-12-22
JP5153049B2 JP5153049B2 (ja) 2013-02-27

Family

ID=26959335

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003539722A Expired - Fee Related JP5153049B2 (ja) 2001-10-29 2002-10-28 膣感染を処置又は予防するための低濃度のペルオキサイド
JP2010152148A Pending JP2010248232A (ja) 2001-10-29 2010-07-02 膣感染を処置又は予防するための低濃度のペルオキサイド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010152148A Pending JP2010248232A (ja) 2001-10-29 2010-07-02 膣感染を処置又は予防するための低濃度のペルオキサイド

Country Status (30)

Country Link
US (1) US7709026B2 (cg-RX-API-DMAC7.html)
EP (1) EP1441769B1 (cg-RX-API-DMAC7.html)
JP (2) JP5153049B2 (cg-RX-API-DMAC7.html)
KR (1) KR101009146B1 (cg-RX-API-DMAC7.html)
CN (1) CN1578676A (cg-RX-API-DMAC7.html)
AR (1) AR037047A1 (cg-RX-API-DMAC7.html)
AT (1) ATE297222T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002346897B2 (cg-RX-API-DMAC7.html)
BR (1) BR0213584A (cg-RX-API-DMAC7.html)
CA (1) CA2465133C (cg-RX-API-DMAC7.html)
DE (1) DE60204584T2 (cg-RX-API-DMAC7.html)
DK (1) DK1441769T3 (cg-RX-API-DMAC7.html)
ES (1) ES2243772T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20040480B1 (cg-RX-API-DMAC7.html)
HU (1) HU229487B1 (cg-RX-API-DMAC7.html)
IL (2) IL161512A0 (cg-RX-API-DMAC7.html)
MA (1) MA26289A1 (cg-RX-API-DMAC7.html)
ME (1) MEP34608A (cg-RX-API-DMAC7.html)
MX (1) MXPA04003977A (cg-RX-API-DMAC7.html)
MY (1) MY137791A (cg-RX-API-DMAC7.html)
NO (1) NO20042199L (cg-RX-API-DMAC7.html)
NZ (1) NZ532294A (cg-RX-API-DMAC7.html)
PE (1) PE20030492A1 (cg-RX-API-DMAC7.html)
PL (2) PL402550A1 (cg-RX-API-DMAC7.html)
PT (1) PT1441769E (cg-RX-API-DMAC7.html)
RS (1) RS51154B (cg-RX-API-DMAC7.html)
RU (1) RU2329829C2 (cg-RX-API-DMAC7.html)
SI (1) SI1441769T1 (cg-RX-API-DMAC7.html)
WO (1) WO2003037382A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200402943B (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8425892B2 (en) * 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
CH697081A5 (de) * 2002-01-22 2008-04-30 Andreas F Dr Schaub Zusammensetzung für die Unterstützung der Geburt eines menschlichen Föten.
US20040126369A1 (en) * 2002-12-30 2004-07-01 Richard Payne Delivery of peroxide-generating enzymes to the vaginal tract
DE10328942A1 (de) * 2003-06-27 2005-01-27 Lts Lohmann Therapie-Systeme Ag Transmukosale Darreichungsformen mit verminderter Schleimhautirritation
ES2237298B1 (es) * 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
US20050276865A1 (en) * 2004-05-20 2005-12-15 Servet Buyuktimkin Peroxide compounds for the prevention and treatment of sexual dysfunction in humans
DE102004054552A1 (de) * 2004-11-11 2006-05-18 Hcb Happy Child Birth Holding Ag Neue Zusammensetzung zur Erleichterung der Humangeburt
ES2344673B1 (es) 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
US10383894B2 (en) * 2010-03-17 2019-08-20 Lutran Industries, Inc. Human medicinal treatment using salt of peroxymonosulfuric acid
US20120074014A1 (en) * 2010-09-27 2012-03-29 Lutran Industries, Inc. Product typically based on salt of peroxymonosulfuric acid and suitable for medicinal usage, and associated product fabrication
US9895311B2 (en) 2014-09-25 2018-02-20 Pharmiva Ab Foam-forming compositions and methods for delivering an active to a body cavity
US20180280340A1 (en) * 2017-03-30 2018-10-04 Konstantin Zubovskiy Method of treating and preventing infections
CN110785163B (zh) 2017-05-23 2023-09-05 法尔米瓦股份公司 用于递送活性剂至体腔的泡沫形成组合物
AU2019365255B2 (en) * 2018-10-26 2025-06-12 Viramal Limited Mucoadhesive gel composition
US11850303B2 (en) * 2020-10-27 2023-12-26 Uqora, Inc. Gel and a suppository and methods to provide the gel and suppository
WO2024231498A1 (en) * 2023-05-09 2024-11-14 BioNTech SE Intravaginal formulations of gardnerella endolysins
TW202541833A (zh) * 2023-12-12 2025-11-01 德商拜恩技術股份公司 包含內溶素之組合物及其用途
WO2025217642A1 (en) * 2024-04-12 2025-10-16 The General Hospital Corporation System and method of treating vaginal infections and inflammation

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2798053A (en) 1952-09-03 1957-07-02 Goodrich Co B F Carboxylic polymers
BE535125A (cg-RX-API-DMAC7.html) 1954-01-25
NL108604C (cg-RX-API-DMAC7.html) 1957-08-27
US4127515A (en) * 1974-10-21 1978-11-28 Colgate-Palmolive Company Waxing sponge
US4607101A (en) * 1981-08-27 1986-08-19 Jaye-Boern Laboratories, Inc. Method of treating acne vulgaris with a composition containing carbamide peroxide
JPH0830004B2 (ja) * 1983-11-14 1996-03-27 コロンビア ラボラトリーズ インコーポレイテッド 生物接着性組成物およびそれにより治療する方法
GB8505402D0 (en) * 1985-03-02 1985-04-03 Ciba Geigy Ag Modified phenolic resins
US4657935A (en) * 1985-07-22 1987-04-14 Carlos Teplicki Real acne control (RAC)
US4923677A (en) 1985-08-07 1990-05-08 Roy T. Witkin Chemical sterilization
US4997625A (en) 1985-08-07 1991-03-05 Simon Gilbert I Chemical sterilization
US4670256A (en) 1985-09-23 1987-06-02 V. Valhalla Corp. Vaginal conditioning for sexual activity
US4781923A (en) * 1987-07-20 1988-11-01 Pellico Michael A Antiseptic gels
US5536743A (en) 1988-01-15 1996-07-16 Curatek Pharmaceuticals Limited Partnership Intravaginal treatment of vaginal infections with buffered metronidazole compositions
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US6017521A (en) * 1989-10-31 2000-01-25 Columbia Laboratories, Inc. Use of polycarboxylic acid polymers to treat vaginal infections
US5376006A (en) 1990-03-22 1994-12-27 Ultradent Products, Inc. Dental bleaching compositions and methods for bleaching teeth surfaces
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5573765A (en) 1991-02-19 1996-11-12 Mark S. Reinhard Composition and method for treatment of vaginal yeast infections
US5340836A (en) 1991-02-19 1994-08-23 Mark S. Reinhard Composition and method for treatment of vaginal yeast infections
IL97930A (en) * 1991-04-23 1996-06-18 Perio Prod Ltd Preparations for whitening two controlled release products that contain a super-oxygen compound
IT1250421B (it) * 1991-05-30 1995-04-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
US5318780A (en) 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5571533A (en) * 1992-02-07 1996-11-05 Recordati, S.A., Chemical And Pharmaceutical Company Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
US5667817A (en) 1992-03-20 1997-09-16 Alcide Corporation Method and composition for prevention and treatment of female lower genital tract microbial infections
US5898037A (en) 1992-11-13 1999-04-27 Marx; Alvin J. Formulations of magnesium compounds for local application and methods of treatment using the same
US5330761A (en) * 1993-01-29 1994-07-19 Edward Mendell Co. Inc. Bioadhesive tablet for non-systemic use products
US5489435A (en) 1993-07-06 1996-02-06 Ratcliff; Perry A. Composition for treatment of abnormal conditions of the epithelium of bodily orifices
US6200557B1 (en) 1993-07-06 2001-03-13 Perry A. Ratcliff Method of treating HIV by a topical composition
US5543150A (en) 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof
UA39965C2 (uk) 1993-12-03 2001-07-16 Лайфор Леборетріз Лтд Вірусоцидний, бактерицидний та руйнуючий сперматозоїди вагінальний засіб і вагінальний супозиторій ( варіанти )
US5667492A (en) * 1994-10-07 1997-09-16 Columbia Laboratories, Inc. Use and composition of an anti-sexually transmitted diseases formulation
US5741525A (en) * 1995-10-24 1998-04-21 Marshall University Research Corporation Vaginal pharmaceutical hydrogen peroxide composition
PT869772E (pt) * 1995-12-27 2002-03-28 Janssen Pharmaceutica Nv Forma galenica solida bioadesiva
US5778886A (en) 1996-02-27 1998-07-14 Shihata; Alfred Vaginal compositions combining a spermicidal agent and a peroxygen compound
US5819742A (en) 1996-11-06 1998-10-13 Family Health International Vaginal device for preventing conception or the transmission of sexually transmitted diseases, or both
US6093394A (en) 1997-04-11 2000-07-25 Gynelogix, Inc. Vaginal lactobacillus medicant
US5843998A (en) * 1997-06-30 1998-12-01 Song; Jin Skin blemish treatment
DE69819748T2 (de) 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
US6248358B1 (en) 1998-08-25 2001-06-19 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets and methods of making and using the same
US6117859A (en) * 1997-11-04 2000-09-12 The Research Foundation Of State University Of New York Method of relieving chronic inflammation by using 5-alkylsulfonylsalicylanilides
JP2002518351A (ja) 1998-06-19 2002-06-25 オキシバイオ・インコーポレイテッド 抗感染および避妊特性を有する医療装置
US6277363B1 (en) 1998-09-21 2001-08-21 Vortech, Inc. Method and composition for treating chlamydia infection
US6159491A (en) 1999-02-12 2000-12-12 Biovector Technologies, Inc. Prolonged release bioadhesive vaginal gel dosage form
EP1267826B1 (en) 1999-10-22 2007-01-03 Lif-Hlaup Ehf. Bio-Gels Pharmaceuticals Inc. Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion
US6200551B1 (en) 2000-01-27 2001-03-13 Susan Ann Morgan Treatment for dry mouth employing carbamide peroxide
US6235314B1 (en) * 2000-08-08 2001-05-22 Sarfaraz K. Niazi Analgesic, anti-inflammatory and skeletal muscle relaxant compositions
JP4086658B2 (ja) * 2000-10-02 2008-05-14 ザ リサーチ ファウンデイション オブ ステイト ユニバーシティー オブ ニューヨーク 抗菌薬および抗炎症剤としてのナフチルサリチルアニリド
US20030211173A1 (en) 2002-05-08 2003-11-13 Veach Tom C. Lubrication composition
US7049000B2 (en) * 2003-08-06 2006-05-23 The Procter & Gamble Company Water-swellable material comprising coated water-swellable polymers
US20090156672A1 (en) * 2007-12-17 2009-06-18 Northwestern University Substituted Phenyl Aziridine Precursor Analogs as Modulators of Steroid Receptor Activities

Similar Documents

Publication Publication Date Title
CN1198625C (zh) 用于治疗粘膜炎、口炎和贝赫切特综合征的药物组合物
JP5458911B2 (ja) 口腔用微生物付着防止剤
RU2004116312A (ru) Перекись в низкой концентрации для лечения или профилактики вагинальных инфекций
Eddy et al. An in vitro evaluation of the antibacterial efficacy of chlorine dioxide on E. faecalis in bovine incisors
PL205148B1 (pl) Zastosowanie chemicznych środków leczniczych
JP2006516571A5 (cg-RX-API-DMAC7.html)
JP3543005B2 (ja) 局所感染の治療
CZ28634U1 (cs) Dentální přípravek na bázi hyaluronanu a oktenidin dihydrochloridu
US10765650B2 (en) Artificial saliva
CN1128614C (zh) 二氯苄醇在制备局部治疗炎症的制剂中的应用和含它的制剂
US10842724B2 (en) Artificial saliva
CN101642467B (zh) 长效消毒膏
Cao et al. Can nasal irrigation with chlorine dioxide be considered as a potential alternative therapy for respiratory infectious diseases? The example of COVID-19
US11278566B2 (en) Agent for use for inflammatory conditions of mucous membranes
CN1092046C (zh) 用于愈合伤口的局部药物组合物
JPH11228387A (ja) ヨード系殺菌剤を含有する薬用組成物
WO2004000253A1 (en) Improved pharmaceutical dental formulations
Saleh et al. COMPARISON BETWEEN EFFICACY OF MIXTURE OF 2% CHLORHEXIDIENE AND CALCIUM HYDROXIDE VS PLACEBO
JPH01283217A (ja) 皮膚疾患治療剤
Dhusia Comparative efficacy and tolerability of microcyn superoxidized solution (oxum) against povidone iodine application in orodental infections
CO5580798A2 (es) Composicion de peroxido de liberacion prolongada para infecciones vaginales
JPS6157514A (ja) 口腔粘膜疾患治療剤
HK1027036B (en) Topical pharmaceutical compositions for wound healing
AU2004222773A1 (en) A method for treatment of mouth lesions
KR20010007717A (ko) 마취력과 살균력을 가진 연고제 및 거즈